The best results for weight reduction are often observed over six months to a year
The decision to use diabetes medications in any combination outside standard guidance would usually be made by a diabetes specialist, taking into account your specific clinical circumstances and with a clear rationale and review plan
Recent reviews (March 2026) consistently praise the welcome calls from team members
Backbone modifications include fatty-acid acylation that supports albumin binding and extends plasma half-life to approximately six days, which underpins the once-weekly subcutaneous dosing pattern used across the published clinical trials
In short: both GLP1 and GIP are part of the bodys incretin system (hormones that act when you eat) and help regulate metabolism
Back Nathan, DM, Schreiber, E, Fogel, H, et al (Feb 1992) 'Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects', Journal Diabetes Care , 15/2, 270-6